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Abstract
Background Acute appendicitis (AA) is the most common general surgical emergency. Early laparoscopic appendicectomy 
is the gold-standard management. SARS-CoV-2 (COVID-19) brought concerns of increased perioperative mortality and 
spread of infection during aerosol generating procedures: as a consequence, conservative management was advised, and 
open appendicectomy recommended when surgery was unavoidable. This study describes the impact of the first weeks of 
the pandemic on the management of AA in the United Kingdom (UK).
Methods Patients 18 years or older, diagnosed clinically and/or radiologically with AA were eligible for inclusion in this 
prospective, multicentre cohort study. Data was collected from 23rd March 2020 (beginning of the UK Government lock-
down) to 1st May 2020 and included: patient demographics, COVID status; initial management (operative and conservative); 
length of stay; and 30-day complications. Analysis was performed on the first 500 cases with 30-day follow-up.
Results The patient cohort consisted of 500 patients from 48 sites. The median age of this cohort was 35 [26–49.75] years 
and 233 (47%) of patients were female. Two hundred and seventy-one (54%) patients were initially treated conservatively; 
with only 26 (10%) cases progressing to an operation. Operative interventions were performed laparoscopically in 44% 
(93/211). Median length of hospital stay was significantly reduced in the conservatively managed group (2 [IQR 1–4] days 
vs. 3 [2–4], p < 0.001). At 30 days, complications were significantly higher in the operative group (p < 0.001), with no deaths 
in any group. Of the 159 (32%) patients tested for COVID-19 on admission, only 6 (4%) were positive.
Conclusion COVID-19 has changed the management of acute appendicitis in the UK, with non-operative management 
shown to be safe and effective in the short-term. Antibiotics should be considered as the first line during the pandemic and 
perhaps beyond.
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Introduction
Acute appendicitis (AA) is the most common general 
surgical emergency worldwide [1]. The lifetime risk of 
developing AA is 6.7% and 8.6% in females and males 
respectively [2]. More than 30,000 appendicectomies are 
performed in England alone each year [3]. Mortality from 
uncomplicated AA is extremely low at 0.1%; however, 
mortality increases with delay in presentation [1]. The risk 
of appendix rupture increases significantly from 36 h after 
onset of symptoms [4]. Gangrenous appendicitis occurs 
in 10% of patients, and perforation or abscess is seen in 
up to one fifth, and both are associated with increased 
complications [5].
In the UK, operative intervention within 48 h of pres-
entation is recommended for AA [6]. Laparoscopic appen-
dicectomy offers clear advantages over open appendicec-
tomy including less postoperative pain, fewer surgical site 
infections, decreased length of hospital stay (LOS), and 
quicker return to normal function [7], and accounts for 
around 94% and 98% of appendicectomies performed in 
males and females respectively [8].
There is a growing evidence base that AA not compli-
cated by gangrene or perforation can be managed without 
surgery [9, 10], is associated with shorter time away from 
work or education, significantly lower overall complication 
rate at 5 years after the episode of AA and is cheaper [11, 
12]. However, AA can return after successful non-opera-
tive management [9]. Despite these considerations, opera-
tive treatment remains the first line treatment for nearly 
all cases of AA in the UK; management with antibiotics 
usually reserved for those presenting with AA complicated 
by phlegmon or abscess [6, 8, 13].
SARS-CoV-2 (COVID-19) brought widespread con-
cerns of the spread of infection during aerosol generat-
ing procedures (AGPs) such as surgery, and particularly, 
laparoscopic surgery [14, 15]. In addition, research into 
COVID positive patients having surgery reported high 
mortality rates even following minor procedures [16]. 
Compounding this, there was a lack of personal protective 
equipment (PPE) for surgeons at the start of the pandemic 
[17]. Consequently, conservative management with anti-
biotics was recommended early in the pandemic by UK 
surgical Royal Colleges as first-line treatment for acute 
uncomplicated AA. To minimise aerosol generation, open 
surgery was recommended over laparoscopic surgery when 
surgery was required [15, 17–20]. Computerised tomogra-
phy (CT) scan was recommended for diagnosing AA and 
the exclusion of perforation or other pathology presenting 
with right iliac fossa pain [20].
The impact of COVID-19 and the impact of recom-
mendations on surgical practice in the UK have not yet 
been fully analysed. An early evaluation of any changes 
in standard UK practice should be performed to assess the 
safety of any move away from first line operative manage-
ment of AA. This will inform practice during the rest of 
the COVID-19 pandemic, and potentially beyond. There is 
the opportunity to observe if the safe and efficient conserv-
ative management of AA previously seen in randomised 
controlled trials and meta-analysis in Europe and the USA 
is generalisable in the UK [21–26]. This interim analysis 
of our study aims to capture the management of AA during 
the first few weeks of the COVID-19 pandemic lockdown 
in the UK and to assess the 30-day outcomes [27].
Materials and methods
Study design
A prospective multicentre study on patients aged ≥ 18 years 
diagnosed either clinically and/or radiologically with AA in 
a secondary care setting was carried out. Data was collected 
from patients presenting from the date of the UK Govern-
ment COVID-19 lockdown on 23rd March 2020. Study reg-
istration was delivered by the local principal investigator at 
each site as either a clinical audit or service evaluation. We 
collected routine, anonymised data that did not influence 
clinical care and published the protocol [27].
Outcomes
The primary aim of this interim analysis was to report on 
the initial management of patients diagnosed with AA from 
the start of the UK lockdown. Outcomes included conserva-
tive or operative management, surgical approach (open or 
laparoscopic), COVID status, Personal Protective Equipment 
(PPE) usage, imaging modality (CT scan; ultrasound[USS]), 
interventional radiology (IR) drain placement, admission to 
critical care [Level 2 (High Dependency Unit) or 3 (Inten-
sive Care Unit)], 30-day complication rate, mortality, and 
length of stay (LOS).
Conservative management was defined as initial treat-
ment with antibiotics and/or IR drainage (i.e., not straight 
to surgery). Acknowledging that the IR drainage group and 
patients with simple appendicitis are different patient popula-
tions, when statistical analysis was performed a comparison 
was made between conservative management group (IR drain 
and antibiotics) versus operative group, and antibiotics alone 
versus operative group. Failure of conservative management 
occurred when conservative management changed to surgery 
after ≥ 2 days after initial assessment. Patient demographics 
and outcomes were analysed in intention to treat by planned 
initial conservative management, even if they progressed to 
surgery later, and those started laparoscopically, even where 
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converted to open intraoperatively, were analysed in the lapa-
roscopic group. LOS is the number of days in hospital during 
the primary admission and is expressed as median.
Site recruitment
All hospitals in the UK that provide emergency care for 
patients diagnosed with AA were eligible to participate. Pub-
licity for the project was supported by The Association of 
Surgeons of Great Britain and Ireland (ASGBI) and the Royal 
College of Surgeons of England (https ://www.rcsen g.ac.uk/
coron aviru s/rcs-covid -resea rch-group /). Regional research col-
laboratives and social media (@covidharem) aided trainee-led 
recruitment of sites.
Data collection
Patients presenting through the emergency department and sur-
gical assessment units were screened by the local teams as per 
the inclusion criteria. Confirmation of local approval allowed 
collaborators to enter fully anonymised data to Research Elec-
tronic Data Capture (REDCap, www.proje ct-redca p.org). The 
database was developed and maintained by the Major Trauma 
Team at Nottingham University Hospitals, UK.
In the interests of providing evidence to help clinicians 
with decision making going forward during the pandemic, 
we have performed an interim analysis of the first 500 
patients submitted with 30-day follow-up.
Statistical analysis
The study was done according to Strengthening the Report-
ing of Observational studies in Epidemiology (STROBE) 
guidelines for observational studies. Descriptive data was 
reported as median [interquartile range (IQR)] or number/
total (%) as appropriate. For all outcomes, proportions were 
reported as the number of events/total patients with data due 
to missing data for some outcomes. When comparing two 
groups with nominal outcomes Chi-squared or Fisher’s exact 
test was used for inferential testing. For continuous, non-nor-
mal data the Mann–Whitney U test was used with p < 0.05 
regarded as the level of statistical significance. Statistical 
analysis was performed using SPSS Version 26 (IBM, www.
ibm.com/uk-en/analy tics/spss-stati stics -softw are) and Stata 
Version 16.1 (StataCorp, www.stata .com).
Results
Patient cohort
From 23rd March 2020 to 1st May 2020, 539 patients were 
entered from 50 sites across the UK (Fig. 1). Participating 
sites were included in this analysis if their data achieved 
95% completion, leaving 500 patients from 48 sites. The 
median age of this cohort was 35 [26–49.75] years and 
233 (47%) of patients were female. Other demographics 
are displayed in Table 1.
Imaging
The majority of patients (425, 85%) had imaging to aid 
diagnosis. CT was the most commonly performed (353, 
71%) throughout all ages in this study, including females 
under 40 years with no difference in frequency of use by 
gender (Table 2). An ultrasound scan was performed in 
86 (17%), with females more likely to undergo ultrasound 
than males (76/233 vs. 10/267, p < 0.001).
Management approach
Two hundred seventy-one (54%) patients were initially 
managed conservatively, while the remaining 229 patients 
(46%) had a plan for surgery within the first day of admis-
sion (Fig. 1). Comparison of the initial conservative ver-
sus operative group found no difference between the two 
groups by sex, frailty score, comorbidities or smoking sta-
tus (Table 1). Patients in the antibiotics alone group were 
younger than the operative group (median age 34 [25–47] 
years versus 37 [28.5–52] years, p = 0.04).
Within the initial conservative group, 263 (97%) 
received solely antibiotic therapy with 5 (2%) having an 
IR drain placed to manage an associated abscess on pri-
mary admission; 3 patients requiring an IR drain due to 
abscess following failed antibiotic management (5, 7 and 
8 days after presentation). Failed conservative manage-
ment occurred in 26 (10%), who went on to have surgery: 
2 of these patients had previously had IR drainage. The 
decision that conservative management had failed and an 
operation was required, was made between 2–29-day post 
initial presentation, with 58% (15) of the decisions being 
made on the 2nd day after admission.
Within the operative group (n = 211), the majority had 
an open procedure 56% (118) versus 44% (93) laparo-
scopic, with a conversion to open reported in 11 patients 
(5%).
Figure  2 displays the week by week proportion of 
patients managed non-operatively and operatively (Fig. 2). 
During the first week of lockdown 35/74 (47%) of patients 
were initially managed conservatively, and of those who 
proceeded to operation, 19 (26%) had laparoscopic surgery 
and 22 (30%) had open surgery. By the third week of lock-
down conservative management peaked at 64% (58/90).
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Patient outcomes and 30‑day follow‑up
LOS in the conservatively managed group, whether patients 
were given antibiotics alone or IR drain placed, was signifi-
cantly less than in those who had an operation (2 [1–4] days 
vs. 3 [2–4] days, p < 0.001, Table 1). LOS was significantly 
lower in the laparoscopic appendicectomy group than the 
open appendicectomy group (2 [2–4] days vs. 3 [2–5] days, 
p < 0·012, Table 3).
At 30-day follow-up there were no reported deaths 
(Table 4). The majority of patients who developed com-
plications were in the operative management group. Intra-
abdominal collections were reported in 27 (6%) cases (19 
in the operative group and 5 in the antibiotics only group, 
p = 0.001). A reoperation, following initial operative inter-
vention was required in a total of 8 patients (2%), while 6 
patients (5 in the operative group), had unplanned admission 
to critical care. At 30 days, the overall complication rate 
(excluding readmissions) was 47/219 in the operative group 
compared to 11/242 in the conservatively managed group 
(p < 0.001).
Of those 26 (10%) managed conservatively that sub-
sequently had an operation, 2 patients required a right 
hemicolectomy: one for complicated AA and the other for 
malignancy. Complications in those in the failed conserva-
tive management group included, 1 post-operative wound 
infection, 1 intra-abdominal collection, 1 unplanned and 
2 planned admissions to critical care. One patient required 
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Fig. 1  Study flow chart
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a second operation. LOS was longer in this group than in 
the straight to operation group (4 days [2–5.5] vs. 3 [2–4] 
, p = 0.03).
Histology demonstrated that 214/241 (89%) of patients 
operated upon had acute appendicitis. Only 6 patients (3%) 
had a histologically normal appendix removed, with the 
remaining 21 (9%) having alternative pathology found at 
operation.
Table 1  Participant characteristics at time of diagnosis and initial management of acute appendicitis
Analysis is separated into operative group versus antibiotics and interventional radiological placed drain (IR drain) and operative group versus 
antibiotics alone. Continuous data is presented as median [IQR]; p values calculated by Mann–Whitney−U. Categorical data are presented as 
number/denominator (percentage); p values calculated by χ2 or Fisher’s exact test as appropriate
The bold typeset in the table highlights statistical significance





ment (n = 229)
Initial conservative management (n = 271)
Antibiotics and IR 
drain (n = 271)
P value Antibiotics alone 
(n = 263)
P value
Age (years) median, range 35 [26–49.75] 37 [28.5–52] 34 [25–48] 0.08 34 [25–47] 0.04
Female 233/500 (47) 99/229 (43) 134/271 (49) 0.18 132/263 (50) 0.13
Body Mass Index kg/m2
  < 20 22/479 (5) 11/222 (6) 11/257 (3) 0.07 11/249 (4) 0.09
 20–25 186/479 (39) 82/222 (37) 104/257 (41) 100/249 (40)
 25–30 165/479 (34) 68/222 (31) 97/257 (38) 94/249 (38)
 30–35 74/479 (15) 45/222 (20) 29/257 (11) 29/249 (12)
 35 + 32/479 (7) 16/222 (8) 16/257 (6) 15/249 (6)
Rockwood score
 Not frail (1–3) 478/500 (96) 220/229 (96) 258/271 (95) 0.87 250/263 (95) 0.84
 Pre-frail (4) 14/500 (3) 6/229 (3) 8/271 (3) 8/263 (3)
 Frail (5–9) 8/500 (2) 3/229 (1) 5/271 (2) 5/263 (2)
Comorbidities
 None reported 450/499 (90) 207/229 (90) 243/270 (90) 1 236/262 (90) 1
 Diabetes 18/499 (3) 9/229 (4) 9/270 (3) 0.81 9/262 (3) 0.81
COPD 9/498 (2) 4/228 (2) 5/270 (2) 1 5/262 (2) 1
 Myocardial infarction 15/498 (3) 8/313 (3) 7/270 (3) 0.61 7/262 (3) 0.61
 Immunosuppressed 11/499 (2) 3/229 (1) 8/270 (3) 0.24 7/262 (3) 0.35
 Active cancer 4/499 (0.7) 3/313 (1) 1/270 (0) 0.3 1/262 (0.4) 0.34
 Dementia 4/499 (0.7) 2/229 (0.6) 2/270 (0.8) 0.87 2/262 (0.8) 1
Imaging
 No Imaging 77/500 (15) 35/229 (15) 42/271 (16) 0.95 42/263 (16) 0.9
 CT scan 353/500 (71) 174/229 (76) 179/271 (66) 0.018 171/263 (65) 0.01
 USS 86/500 (17) 26/229 (11) 60/271 (22) 0.002 60/263 (23) 0.001
 CT scan and USS 16/500 (3) 6/229 (2) 10/271 (3) 0.61 10/263 (4) 0.61
Admission COVID swab
 Positive 6/159 (4) 3/91 (3) 3/68 (4) 1 3/64 (5) 0.69
 Negative 153/159 (96) 88/91 (97) 65/68(96) 61/64 (90)
Not performed 341/500 (68) 138/229 (60) 203/271(75)  < 0.001 199/263 (76)  < 0.001
Length of stay (days)
median, range
3 [1–4] 3 [2–4] 2 [1–4]  < 0.001 2 [1–4]  < 0.001
Managed without admission 57/483 (12) 9/223 (4) 48/260 (18)  < 0.001
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COVID‑19 and PPE
At presentation, 159 (32%) of patients were swabbed for 
COVID-19 with 6 (4%) positive results. Three of these 
patients had an operation, and 1 required reoperation. 
Patients managed conservatively initially were less likely 
to have a COVID swab (68/271 (25%), p < 0.001). Post-
presentation, a further 4 patients that had all been swab 
negative on presentation, were found to have COVID. Of 
these, 2 had an operation. None of the 10 COVID positive 
patients required critical care, and there was no mortality 
at 30 days.
Through the study period use of filtering facepiece 
assigned protection factor 3 (FFP3) during appendicectomy 
increased from use in less than 60% of cases to nearly 100% 
(Fig. 3).
Discussion
Disruption caused by COVID-19 has rapidly changed the 
management of AA in the UK, with a clear shift to con-
servative management. Though previously rarely used, con-
servative management of AA, whether with antibiotics alone 
or IR drain, has been effectively applied in the majority of 
patients in this study. With only 10% failing such manage-
ment and requiring surgery, a shorter LOS and fewer com-
plications compared to those who had initial operations, this 
interim analysis supports previous studies that have reported 
non-operative management of AA as a safe and effective 
option [21–26]. This study reassures surgeons about their 
decision making during the pandemic, supports routine CT 
imaging to aid such decisions and demonstrates that this 
option is generalisable in UK practice and perhaps, signals 
a reconsideration for first line treatment of AA beyond the 
pandemic.
Evolution of AA management in the UK 
during the COVID‑19 pandemic
On 20th March 2020, a leading UK surgical professional 
association issued COVID-19 guidance that stated “non-
surgical solutions to be used to avoid surgery where pos-
sible” [17]. As of a direct result of this, normal practice 
in the UK of early laparoscopic appendicectomy for adult 
AA immediately changed to over half of patients being con-
servatively managed and of those having an operation, the 
majority having an open procedure. Strengthened by greater 
patient numbers having imaging, the positive short-term 
outcomes from conservative management support this guid-
ance. As the pandemic evolves, professional bodies continue 
to provide updated guidance. This may be reflected in further 
management shifts that will be seen in the planned longer 
term follow-up of this study.
Imaging in the diagnosis of appendicitis
Recently published work from the UK reported that almost 
40% of patients had no imaging to support a clinical diag-
nosis of AA [8]. In contrast, our data shows 85% of patients 
had imaging with CT the favoured modality. Age and sex 
were not barriers, with CT scan very commonly used in 
younger patients and more frequently in women of reproduc-
tive age than before the pandemic [8]. Comparison with the 
recent UK observational study on right iliac fossa pain finds 
only 15% of their female patients had a CT scan, compared 
to 70% in this study [8]. In addition to aiding a decision for 
conservative management of AA, it is possible that clini-
cians wanted a definitive diagnosis of AA before embark-
ing on an operative procedure that carried potentially higher 
Table 2  Computed tomography scans performed by age group
There was a significant difference between age groups in CT scans 
performed (p < 0.001). Number and total (%) within each age group 
category; p values calculated by χ2
Age group Computed 
Tomography 
(CT) scan
Females Males P value
18–39 years 165/300 (55) 74/144 (51) 91/156 (58) 0.23
40–59 years 118/128 (92) 46/52 (88) 72/76 (95) 0.07
60 years and 
above
70/72 (97) 36/37 (97) 34/35 (97) 1
Fig. 2  Percentage of patients treated nonoperatively (blue), with lapa-
roscopic appendicectomy (red), and open appendicectomy (green) on 
a week by week basis during the pandemic
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risks for both patient and operating room staff [15]. CT is 
highly sensitive at detecting AA and is known to reduce 
the rate of negative appendicectomies significantly, making 
routine CT imaging perhaps with a lower radiation dose a 
future consideration [28]. It is not apparent why patients in 
this study who had an USS were significantly more likely 
to have conservative management. It may be that they were 
clinically less convincing and the USS was used to exclude 
other pathology (especially gynaecological) rather than con-
firm appendicitis. Alternatively, the sonographers may have 
preferred USS to make the diagnosis of AA, rather than CT 
scan, an approach that is recommended by the recent WSES 
Jerusalem Guidelines [9].
Operative and non‑operative management of AA
There were no differences between initial operative and 
conservative groups in the patient characteristics recorded 
other than age, highlighting that clinical decision-making 
for these patients may be multifactorial, including individual 
interpretation of the new guidelines, local surgical set-up for 
imaging and theatre access, surgical experience and patient 
preference. However, 9 out of 10 of those treated with anti-
biotics alone needed no operative intervention and stayed for 
a shorter time in hospital, supporting previous evidence for a 
non-operative strategy in AA [9, 11, 12]. For those initially 
conservatively managed who came to surgery, reassuringly 
this was a small number (10%) with the majority of deci-
sions for surgery taken early during the admission (58% at 
day 2). Overall, those who failed conservative management 
did not have significantly poorer outcomes when compared 
to those having initial surgery. Although a longer LOS was 
reported in this group, this is to be expected as total LOS 
will include the conservative management days. Of the 2 
right hemicolectomies performed in this group, one was for 
complicated appendicitis, and the other for malignancy.
The observations in this study are in keeping with pre-
vious reports of non-operative management being safe 
and effective for the majority of patients, with other stud-
ies reporting similar success rates, reduced social costs to 
the patient and less financial cost to the healthcare system 
if conservative management is considered as a treatment 
option for AA [9, 11, 12, 21–26]. However, many of these 
studies were conducted in a research setting, where specific 
Table 3  Comparison of 
operative management for adult 
acute appendicitis: open versus 
laparoscopic appendicectomy
Laparoscopic converted to open included in the laparoscopic group. 19 cases excluded due to insufficient 
information. Continuous data is presented as median [IQR]; p values calculated by Mann–Whitney−U. 
Categorical data are presented as number/denominator (percentage); p values calculated by χ2 or Fisher’s 
exact test as appropriate
The bold typeset in the table highlights statistical significance
*Unless otherwise indicated
Event/Total (%)* Open (n = 133) Laparoscopic (n = 104) P value
Age (years)
median, range
35 [29–51.5] 37.5 [25–53] 0.934
Female 47/133 (35) 56/104 (54) 0.006
No comorbidity 119/133 (90) 95/104 (91) 0.665
Time of day of operation
 8 am–6 pm 87/133 (66) 62/102 (61) 0.135
 6 pm–10 pm 32/133 (24) 20/102 (20)
 10 pm–8 am 14/133 (11) 20/102 (20)
Operative time
  < 30 min 3/133 (2) 5/102 (5) 0.612
 30−60 min 53/133 (40) 44/102 (43)
 60–90 min 57/133 (43) 35/102 (34)
 90–120 min 16/133 (16) 14/102 (14)
  > 120 min 4/133 (3) 4/102 (4)
Consultant performed procedure 49/133 (37) 33/103 (32) 0.173
Consultant performing or assisting 72/133 (54) 42/103 (41) 0.04
Postoperative care
 Level 2 High Dependency Unit 4/133 (3) 3/103 (3) 0.749
 Level 3 Intensive Care Unit 3/133 (2) 1/103 (1)
Converted to open from laparoscopic – 11/104 (11) –
Length of stay (days)
median, range
3 [2–5] 2 [2–4] 0.012
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inclusion criteria were applied. This contrasts sharply with 
our study, where all adults irrespective of their presentation, 
age, or CT scan findings were included.
Laparoscopic versus open surgery
Within this study cohort, 56% (133/237) patients having an 
operation had an open procedure. This is at significant odds 
with UK practice prior to the pandemic, where only a small 
number of patients were having open procedures (0.4%) [8]. 
This is likely due to guidance issues that suggested lapa-
roscopic surgery should be avoided due to concerns about 
AGPs [17, 29].
COVID‑19
The UK has been one of the hardest hit countries during 
the global COVID-19 pandemic, with the second highest 
reported mortality rate as of the beginning of June 2020 
[30]. Despite this, only 32% of patients were swabbed for 
COVID-19 at presentation. Local policies for swabbing 
Table 4  Thirty-day outcome data of initial operative versus conservative management with separate analyses for operative management versus 
antibiotics and interventional radiology drain placement and operative management versus antibiotics alone
Categorical data are presented as number/denominator (percentage); p values calculated by χ2 or Fisher’s exact test as appropriate
The bold typeset in the table highlights statistical significance
IR Interventional radiolog placement of, IV Intravenous
*Collection refers to an infected fluid collection or intra−abdominal abscess requiring treatment **Ileus was defined as a partial or complete 
non−mechanical blockade of the small intestine ***Wound infection includes both superficial and deep incisional surgical site infection, defined 
according to Center for Disease Control criteria as superficial “involving only skin and subcutaneous tissues” and deep as “involving deep struc-




ment (n = 219)
Initial conservative management
(n = 251)
Antibiotics and IR 
drain (n = 251)
P value Antibiotics alone 
(n = 244)
P value
Collection* 27/470 (6) 19/219 (8) 8/251 (4) 0.01 5/244 (2) 0.001
Collection requiring IR drain 3/470 (1) 0/219 (0) 3/251 (1) 0.252 0/244 (0)
Collection requiring re-operation 6/470 (1) 5/219 (2) 1/251 (0) 0.102 0/244 (0)
Ileus** 14/470 (4) 14/219 (8) 0/251 (0)  < 0.001 0/244 (0)  < 0.001
Wound infection***
Antibiotics 18/470 (3) 16/219 (7) 2/251 (1)  < 0.001 2/242 (0.8)  < 0.001
Wound Opened 9/470 (2) 8/219 (4) 1/251 (1) 0.014 1/244 (0.4) 0.02
Hospital Acquired Pneumonia
Oral Antibiotics 1/470 (0.2) 1/219 (0.5) 0/251 (0) 1 0/244 (0) 0.47
IV Antibiotics 6/470 (2) 6/219 (3) 0/251 (0) 0.01 0/244 (0) 0.01
Deep Vein Thrombosis/ Pulmonary 
Embolism
3/470 (0.2) 1/219 (0.5) 2/251 (1) 1 2/244 (1) 1
Reoperation**** 8/470 (2) 7/219 (3) 1/251 (0) 0.03 0/244 (0) 0.005
Death 0/470 (0) 0/219 (0) 0/251 (0) 1 0/244 (0) 1
Unplanned level 2/3 care 6/470 (2) 5/219 (4) 1/251 (0) 0.1 1/243 (0.4) 0.11
Post presentation COVID 7/470 (1) 4/219 (2) 3/251 (1) 0.71 3/244 (1) 0.71
Failed conservative management – – 26/251 (10) – 24/244 (9) –
Fig. 3  Type of Personal Protective Equipment (PPE) used when per-
forming appendicectomy by week of the study. FFP3 mask (blue), 
standard surgical mask (red), none (green), and other (orange)
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were not recorded and are highly likely to have varied 
across the UK during the early phase of the pandemic. 
Follow-up work may show greater rates of testing.
Only 4% tested positive for the virus with poorer out-
comes not reported, irrespective of whether having sur-
gery or conservative management. This is in contrast to 
recent reports of an increase in mortality after even minor 
to moderate surgery [16]. However, most patients with AA 
are young and otherwise fit, which would predispose them 
to better outcomes than those reported for a broad variety 
of operative interventions [16].
Strengths and weaknesses
This is a large multicentre study of current AA practice 
in the UK with high data completion. Early analysis has 
allowed prompt reporting of a change in surgical practice 
to be demonstrated as safe in the short-term, reassuring sur-
geons in the current complex clinical climate and aiding 
decision-making in the case of a second viral wave; these 
findings are likely to be generalisable to other populations 
who normally defer to operative intervention, but whose 
practice has been disrupted by COVID-19, such as the 
United States and Europe.
The authors acknowledge that this is a pragmatic study, 
where bias may exist in the decision for initial management. 
Such bias may be a consequence of the initial conservative 
management group presenting with less severe symptoms 
compared to the initial operative group. We also appreci-
ate that patients having laparoscopy without appendicec-
tomy may not have been included in this data set, leading 
to an underestimation of the negative appendicectomy rate. 
One further limitation of the study is the lack of assess-
ment of confounding variables on outcome data; this will be 
explored in future work with a larger dataset and maturation 
of follow-up to assess for longer term outcomes.
Conclusions
The COVID-19 pandemic markedly disrupted the usual sur-
gical management of acute appendicitis in the UK with con-
servative management favoured. In this setting non-operative 
management of AA appears to be an effective first line treat-
ment regardless of sex, co-morbidity or frailty, with only 
a minority requiring surgery as a second line. Disruption 
allows change, and these early findings should inform the 
continued management of AA during the COVID-19 pan-
demic and perhaps beyond.
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